Cargando…
Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
BACKGROUND: Childhood interstitial lung disease (chILD) represents a rare heterogeneous group of respiratory disorders. In the absence of randomized controlled clinical trials, global collaborations have utilized case series with an aim to standardising approaches to diagnosis and management. Austra...
Autores principales: | Saddi, Vishal, Beggs, Sean, Bennetts, Bruce, Harrison, Joanne, Hime, Neil, Kapur, Nitin, Lipsett, Jill, Nogee, Lawrence M., Phu, Amy, Suresh, Sadasivam, Schultz, André, Selvadurai, Hiran, Sherrard, Stephanie, Strachan, Roxanne, Vyas, Julian, Zurynski, Yvonne, Jaffé, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526310/ https://www.ncbi.nlm.nih.gov/pubmed/28743279 http://dx.doi.org/10.1186/s13023-017-0637-x |
Ejemplares similares
-
Childhood interstitial lung disease due to surfactant protein C deficiency: frequent use and costs of hospital services for a single case in Australia
por: Hime, Neil J, et al.
Publicado: (2014) -
Screening for Cystic Fibrosis Related Complications in the Context of a Pandemic and Altered Models of Care
por: Doumit, Michael, et al.
Publicado: (2023) -
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life
por: Kelada, Lauren, et al.
Publicado: (2022) -
Bacterial Causes of Empyema in Children, Australia, 2007–2009
por: Strachan, Roxanne E., et al.
Publicado: (2011) -
The role of exome sequencing in childhood interstitial or diffuse lung disease
por: Temple, Suzanna E. L., et al.
Publicado: (2022)